Avivomed
PrivateLast Round
Seed Round
Apr 16, 2026
Total Funding Raised
$32M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avivomed operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Series A round in December 2021.
Avivomed is a medical device company that develops and commercializes next-generation minimally invasive neuromodulation therapies for patients suffering from obstructive sleep apnea and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avivomed Comparables
Compare Avivomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lunair Medical | 94% | |
| XII Medical | 92% | |
| StimAire | 89% |
For institutional investors. Book with your work email.
Avivomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 16, 2026 | ||||
| Series A | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avivomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series A |
| Hatteras Venture Partners | Series A |
| Norwest Venture Partners | Series A |
| F-Prime Capital | Series A |
| Treo Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 369% MoM, reaching 1.5K.
- Apr 16, 2026
$5M round raised
For institutional investors. Book with your work email.
Avivomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avivomed's valuation, stock price, and market status.
Is Avivomed a public or private company?
Avivomed is a private company.
What is the current stock price of Avivomed?
Avivomed is a private company, so its shares have no public market price. Caplight tracks Avivomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avivomed worth (valuation)?
Valuation information for Avivomed is not publicly available.
Can I buy Avivomed stock?
Avivomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avivomed's last funding round?
Avivomed's most recent funding round was Seed Round on April 16, 2026.
Who are the main investors in Avivomed?
Key investors in Avivomed include F-Prime Capital, Hatteras Venture Partners, Norwest Venture Partners, F-Prime Capital, Treo Ventures.
Will Avivomed IPO soon?
No public IPO plans have been announced for Avivomed.
How can I track Avivomed secondary market activity?
Caplight tracks bids, offers, and trades in Avivomed's shares on secondary markets.